These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 23220353)

  • 1. Therapeutic strategies evaluated by the European Society of Cutaneous Lupus Erythematosus (EUSCLE) Core Set Questionnaire in more than 1000 patients with cutaneous lupus erythematosus.
    Sigges J; Biazar C; Landmann A; Ruland V; Patsinakidis N; Amler S; Bonsmann G; Kuhn A;
    Autoimmun Rev; 2013 May; 12(7):694-702. PubMed ID: 23220353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous lupus erythematosus: first multicenter database analysis of 1002 patients from the European Society of Cutaneous Lupus Erythematosus (EUSCLE).
    Biazar C; Sigges J; Patsinakidis N; Ruland V; Amler S; Bonsmann G; Kuhn A;
    Autoimmun Rev; 2013 Jan; 12(3):444-54. PubMed ID: 23000206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of smoking on disease severity and antimalarial therapy in cutaneous lupus erythematosus: analysis of 1002 patients from the EUSCLE database.
    Kuhn A; Sigges J; Biazar C; Ruland V; Patsinakidis N; Landmann A; Amler S; Bonsmann G;
    Br J Dermatol; 2014 Sep; 171(3):571-9. PubMed ID: 24673427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of the EUSCLE Core Set Questionnaire for the assessment of cutaneous lupus erythematosus.
    Kuhn A; Patsinakidis N; Bonsmann G
    Lupus; 2010 Aug; 19(9):1144-52. PubMed ID: 20693209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a Core Set Questionnaire by the European Society of Cutaneous Lupus Erythematosus (EUSCLE).
    Kuhn A; Kuehn E; Meuth AM; Haust M; Nyberg F; Werth V; Ruzicka T; Schmitt V; Bonsmann G;
    Autoimmun Rev; 2009 Jul; 8(8):702-12. PubMed ID: 19232553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous lupus erythematosus: update of therapeutic options part I.
    Kuhn A; Ruland V; Bonsmann G
    J Am Acad Dermatol; 2011 Dec; 65(6):e179-93. PubMed ID: 20739095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A database analysis of cutaneous lupus erythematosus with the EUSCLE Core Set Questionnaire.
    Meuth AM; Amler S; Haust M; Bein D; Sauerland C; Köpcke W; Bonsmann G; Nyberg F; Kuhn A
    Acta Derm Venereol; 2010 Jul; 90(4):386-94. PubMed ID: 20574604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The study of Cutaneous Lupus Erythematosus Disease Area and Severity Index in Indian patients with systemic lupus erythematosus.
    Salphale P; Danda D; Chandrashekar L; Peter D; Jayaseeli N; George R
    Lupus; 2011 Dec; 20(14):1510-7. PubMed ID: 21997966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of cutaneous lupus erythematosus: current practice variations.
    Reich A; Werth VP; Furukawa F; Kuhn A; Szczęch J; Samotij D; Szepietowski JC
    Lupus; 2016 Aug; 25(9):964-72. PubMed ID: 26821963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics of cutaneous lupus erythematosus.
    Szczęch J; Rutka M; Samotij D; Zalewska A; Reich A
    Postepy Dermatol Alergol; 2016 Feb; 33(1):13-7. PubMed ID: 26985173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S2k guideline for treatment of cutaneous lupus erythematosus - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV).
    Kuhn A; Aberer E; Bata-Csörgő Z; Caproni M; Dreher A; Frances C; Gläser R; Klötgen HW; Landmann A; Marinovic B; Nyberg F; Olteanu R; Ranki A; Szepietowski JC; Volc-Platzer B
    J Eur Acad Dermatol Venereol; 2017 Mar; 31(3):389-404. PubMed ID: 27859683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural history of disease activity and damage in patients with cutaneous lupus erythematosus.
    Ker KJ; Teske NM; Feng R; Chong BF; Werth VP
    J Am Acad Dermatol; 2018 Dec; 79(6):1053-1060.e3. PubMed ID: 29969701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicohistological and immunopathological features of patients with cutaneous lupus erythematosus at tertiary dermatology centre in Malaysia.
    Teh YC; Loo CH; Mohd Ali N; Lim AL; Tan WC
    Clin Exp Dermatol; 2022 Aug; 47(8):1490-1501. PubMed ID: 35315538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Varied responses to and efficacies of hydroxychloroquine treatment according to cutaneous lupus erythematosus subtypes in Japanese patients.
    Ototake Y; Yamaguchi Y; Kanaoka M; Akita A; Ikeda N; Aihara M
    J Dermatol; 2019 Apr; 46(4):285-289. PubMed ID: 30719729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of disease activity and damage in different subtypes of cutaneous lupus erythematosus using the CLASI.
    Bein D; Kuehn E; Meuth AM; Amler S; Haust M; Nyberg F; Sauerland C; Luger TA; Bonsmann G; Kuhn A
    J Eur Acad Dermatol Venereol; 2011 Jun; 25(6):652-9. PubMed ID: 20849444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of cutaneous lupus.
    Chang AY; Werth VP
    Curr Rheumatol Rep; 2011 Aug; 13(4):300-7. PubMed ID: 21503694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cutaneous lupus erythematosus disease area and severity index: a responsive instrument to measure activity and damage in patients with cutaneous lupus erythematosus.
    Bonilla-Martinez ZL; Albrecht J; Troxel AB; Taylor L; Okawa J; Dulay S; Werth VP
    Arch Dermatol; 2008 Feb; 144(2):173-80. PubMed ID: 18283174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the Cutaneous Lupus Disease Area and Severity Index (CLASI) using physician- and patient-assessed health outcome measures.
    Jolly M; Kazmi N; Mikolaitis RA; Sequeira W; Block JA
    J Am Acad Dermatol; 2013 Apr; 68(4):618-623. PubMed ID: 23107310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Skin manifestations in lupus erythematosus: clinical aspects and therapy].
    Kuhn A; Ruland V; Bonsmann G
    Z Rheumatol; 2011 Apr; 70(3):213-26; quiz 227. PubMed ID: 21494937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of smoking in cutaneous lupus erythematosus.
    Piette EW; Foering KP; Chang AY; Okawa J; Ten Have TR; Feng R; Werth VP
    Arch Dermatol; 2012 Mar; 148(3):317-22. PubMed ID: 22105815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.